CYBERnano is a contract research organization founded in 2013 which provides innovative services in data science to facilitate the implementation of Quality-by-Design studies (ICH Q8-Q12) in Health industry (Drugs and Medical Devices). CYBERnano’s staff is involved in the development of innovative statistical methods for the design of experiments and data analysis to better predict risks related to efficacy, quality and safety requirements. To facilitate QbD studies, CYBERnano has also developed a web platform: easyQbD in which methods and tools of risk assessment have been fully integrated. This platform is already used in several collaborative projects involving European partners. Moreover with the biologIA service, we develop for you tailor-made software to automate your data analysis.
Our team is composed of three scientific researchers, one business developer and five engineers in data science, computer science and biology.
We are dynamic, responsive and motivated to meet your unmet needs.
Co-Founder, Scientific Expert in Biostatistics and Nano-informatics
Expert in Nano-Cancerology
Co-Founder, Expert in